{"title": "The story of GARP: A potential target for cancer immunotherapy", "title_detail": {"type": "text/plain", "language": null, "base": "https://www.sciencedaily.com/rss/health_medicine/cancer.xml", "value": "The story of GARP: A potential target for cancer immunotherapy"}, "links": [{"rel": "alternate", "type": "text/html", "href": "https://www.sciencedaily.com/releases/2019/03/190318132615.htm"}], "link": "https://www.sciencedaily.com/releases/2019/03/190318132615.htm", "summary": "Researchers reveal how the cell surface receptor GARP plays a role in T regulatory cell function and migration to the gut. Because the presence of T regulatory cells in the gut is generally associated with negative outcomes in patients with colorectal cancer, GARP could have potential as a therapeutic target for patients with this type of cancer.", "summary_detail": {"type": "text/html", "language": null, "base": "https://www.sciencedaily.com/rss/health_medicine/cancer.xml", "value": "Researchers reveal how the cell surface receptor GARP plays a role in T regulatory cell function and migration to the gut. Because the presence of T regulatory cells in the gut is generally associated with negative outcomes in patients with colorectal cancer, GARP could have potential as a therapeutic target for patients with this type of cancer."}, "published": "Mon, 18 Mar 2019 13:26:15 EDT", "published_parsed": [2019, 3, 18, 17, 26, 15, 0, 77, 0], "id": "https://www.sciencedaily.com/releases/2019/03/190318132615.htm", "guidislink": false}